Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosis.
Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach.
Intravenous immunoglobulin preparation attenuates neurological signs in rat experimental autoimmune neuritis with the suppression of macrophage inflammatory protein -1α expression.
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.
Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters.
Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis.
Difficulties in Planning Among Patients with Multiple Sclerosis: A Relative Consequence of Deficits in Information Processing Speed.
Disutility of Illness for Caregivers and Families: A Systematic Review of the Literature.
Predictive value of 1 month retinal nerve fiber layer thinning for deficits at 6 months after acute optic neuritis.
Depletion of Olig2 in oligodendrocyte progenitor cells infected by Theiler's murine encephalomyelitis virus.
Importance of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of the Treatment Efficacy in Multiple Sclerosis Patients with Acute Attacks.
Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy.
Potential For Cell-mediated Immune Responses In Mouse Models Of Pelizaeus-Merzbacher Disease.
Pathologic and imaging correlates of cognitive deficits in multiple sclerosis: changing the paradigm of diagnosis and prognosis.
No evidence for an association of osteopontin plasma levels with disease activity in multiple sclerosis.
From precursors to myelinating oligodendrocytes: Contribution of intrinsic and extrinsic factors to white matter plasticity in the adult brain.
Ipilimumab in patients with melanoma and autoimmune disease.
Multiple sclerosis at menopause: Potential neuroprotective effects of estrogen.
Natalizumab to fingolimod: Questions answered, unanswered, and unasked.
Functional connectivity underlying postural motor adaptation in people with multiple sclerosis.
Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis.
Cost-effectiveness of an adjustment group for people with multiple sclerosis and low mood: a randomized trial.
An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis.
New Poteintial Serum Biomarkers in Multiple Sclerosis Identified by Proteomic Strategies.
Comparison of diabetes patients with "demyelinating" diabetic sensorimotor polyneuropathy to those diagnosed with CIDP.
Pages
« first
‹ previous
…
561
562
563
564
565
566
567
568
569
…
next ›
last »